Daewoong Pharmaceutical Co., Ltd (KRX:069620)
149,600
-2,300 (-1.51%)
At close: Apr 29, 2026
Daewoong Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 168,942 | 102,950 | 111,506 | 102,951 | 75,907 | Upgrade
|
| Short-Term Investments | 3,860 | 5,077 | 3,000 | 10,000 | 97,827 | Upgrade
|
| Trading Asset Securities | - | 8,320 | 23,179 | 27,700 | - | Upgrade
|
| Cash & Short-Term Investments | 172,801 | 116,347 | 137,685 | 140,651 | 173,734 | Upgrade
|
| Cash Growth | 48.52% | -15.50% | -2.11% | -19.04% | -1.91% | Upgrade
|
| Accounts Receivable | 166,724 | 160,742 | 137,506 | 142,165 | 121,591 | Upgrade
|
| Other Receivables | 48,336 | 51,150 | 40,386 | 36,979 | 36,916 | Upgrade
|
| Receivables | 215,161 | 211,894 | 177,892 | 179,144 | 159,508 | Upgrade
|
| Inventory | 310,876 | 256,353 | 241,545 | 208,736 | 170,559 | Upgrade
|
| Prepaid Expenses | 17,896 | 15,950 | 8,534 | 7,598 | 6,604 | Upgrade
|
| Other Current Assets | 15,624 | 12,248 | 9,168 | 12,840 | 9,996 | Upgrade
|
| Total Current Assets | 732,358 | 612,792 | 574,824 | 548,968 | 520,401 | Upgrade
|
| Property, Plant & Equipment | 842,341 | 675,666 | 521,919 | 440,890 | 395,866 | Upgrade
|
| Long-Term Investments | 250,179 | 180,703 | 203,792 | 146,335 | 118,369 | Upgrade
|
| Goodwill | 60,848 | 60,848 | 60,848 | 60,848 | 60,848 | Upgrade
|
| Other Intangible Assets | 78,106 | 83,069 | 80,001 | 84,620 | 81,406 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 569.7 | Upgrade
|
| Long-Term Deferred Tax Assets | 78,580 | 68,786 | 71,304 | 64,136 | 58,565 | Upgrade
|
| Long-Term Deferred Charges | 228,570 | 202,793 | 156,636 | 120,540 | 82,915 | Upgrade
|
| Other Long-Term Assets | 88,475 | 88,613 | 97,660 | 93,745 | 91,747 | Upgrade
|
| Total Assets | 2,362,799 | 1,976,977 | 1,770,311 | 1,563,341 | 1,410,687 | Upgrade
|
| Accounts Payable | 106,234 | 83,043 | 101,099 | 83,401 | 70,852 | Upgrade
|
| Accrued Expenses | 24,963 | 24,010 | 24,085 | 20,635 | 15,485 | Upgrade
|
| Short-Term Debt | 70,829 | 206,495 | 167,426 | 141,742 | 56,109 | Upgrade
|
| Current Portion of Long-Term Debt | 205,947 | 115,000 | 204,943 | 91,931 | 199,878 | Upgrade
|
| Current Portion of Leases | 1,171 | 2,002 | 1,961 | 1,183 | 987.32 | Upgrade
|
| Current Income Taxes Payable | 11,545 | 8,146 | 14,497 | 4,906 | 4,734 | Upgrade
|
| Current Unearned Revenue | 14.84 | 76.15 | 59.22 | 30.67 | - | Upgrade
|
| Other Current Liabilities | 168,120 | 155,573 | 153,047 | 129,004 | 112,615 | Upgrade
|
| Total Current Liabilities | 588,823 | 594,346 | 667,117 | 472,831 | 460,660 | Upgrade
|
| Long-Term Debt | 550,561 | 324,478 | 65,000 | 204,840 | 181,713 | Upgrade
|
| Long-Term Leases | 882.62 | 1,274 | 1,941 | 7,015 | 7,008 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 722.46 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1,615 | 3,530 | 5,009 | 4,053 | 3,580 | Upgrade
|
| Other Long-Term Liabilities | 86,262 | 90,573 | 90,547 | 133,378 | 59,811 | Upgrade
|
| Total Liabilities | 1,228,144 | 1,014,923 | 829,614 | 822,118 | 712,772 | Upgrade
|
| Common Stock | 28,966 | 28,966 | 28,966 | 28,966 | 28,966 | Upgrade
|
| Additional Paid-In Capital | 149,816 | 149,892 | 149,175 | 121,582 | 123,649 | Upgrade
|
| Retained Earnings | 833,595 | 635,674 | 618,864 | 504,294 | 467,361 | Upgrade
|
| Treasury Stock | -2,850 | -2,850 | -2,850 | -18,360 | -18,360 | Upgrade
|
| Comprehensive Income & Other | -3,435 | -17,044 | -26,852 | -28,466 | -32,085 | Upgrade
|
| Total Common Equity | 1,006,093 | 794,640 | 767,303 | 608,017 | 569,531 | Upgrade
|
| Minority Interest | 128,562 | 132,345 | 144,978 | 133,206 | 128,384 | Upgrade
|
| Shareholders' Equity | 1,134,656 | 962,055 | 940,696 | 741,223 | 697,915 | Upgrade
|
| Total Liabilities & Equity | 2,362,799 | 1,976,977 | 1,770,311 | 1,563,341 | 1,410,687 | Upgrade
|
| Total Debt | 829,390 | 649,249 | 441,270 | 446,711 | 445,695 | Upgrade
|
| Net Cash (Debt) | -656,589 | -532,902 | -303,585 | -306,060 | -271,961 | Upgrade
|
| Net Cash Per Share | -57063.54 | -46314.03 | -26572.35 | -27649.69 | -24713.54 | Upgrade
|
| Filing Date Shares Outstanding | 11.51 | 11.51 | 11.51 | 11.07 | 11.07 | Upgrade
|
| Total Common Shares Outstanding | 11.51 | 11.51 | 11.51 | 11.07 | 11.07 | Upgrade
|
| Working Capital | 143,535 | 18,447 | -92,293 | 76,137 | 59,742 | Upgrade
|
| Book Value Per Share | 87438.70 | 69061.46 | 66685.66 | 54928.72 | 51451.87 | Upgrade
|
| Tangible Book Value | 867,140 | 650,723 | 626,454 | 462,550 | 427,278 | Upgrade
|
| Tangible Book Value Per Share | 75362.36 | 56553.74 | 54444.60 | 41787.05 | 38600.56 | Upgrade
|
| Land | 89,212 | 83,840 | 97,598 | 94,459 | 69,482 | Upgrade
|
| Buildings | 316,093 | 296,280 | 267,669 | 261,085 | 247,556 | Upgrade
|
| Machinery | 379,247 | 360,301 | 340,864 | 325,145 | 307,618 | Upgrade
|
| Construction In Progress | 400,304 | 267,131 | 131,731 | 58,328 | 47,216 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.